Cevher Ozcan, MD, is a highly skilled cardiologist with an expertise in heart rhythm disorders. Dr. Ozcan has a primary focus in pharmacological and non-pharmacological treatment of arrhythmias and conduction disease, including supraventricular tachycardia, atrial fibrillation, atrial flutter, ventricular arrhythmia, sudden cardiac arrest, syncope arrhythmias in women and inherited arrhythmias. She also specializes in use of antiarrhythmic medications, catheter ablation and cardiac implantable electrical devices, such as pacemakers and defibrillators.
As an active researcher, Dr. Ozcan is investigating mechanisms and treatments of cardiac electrophysiological diseases through clinical, basic and translational research. Currently, she is examining the molecular mechanisms of atrial fibrillation and complex arrhythmias in order to develop novel therapeutic strategies for prevention and treatment of arrhythmias. Her pivotal manuscripts provided the framework for effective pharmacological and non-pharmacological treatment of atrial fibrillation and other arrhythmias.
Limited benefit of half-normal vs normal saline irrigation for augmenting current delivery with open-irrigated temperature-controlled ablation.
Limited benefit of half-normal vs normal saline irrigation for augmenting current delivery with open-irrigated temperature-controlled ablation. Heart Rhythm O2. 2026 Aug; 7(8):1555-1563.
PMID: 42666866
Impact of atrial arrhythmias on long-term survival in non-small cell lung cancer patients.
Impact of atrial arrhythmias on long-term survival in non-small cell lung cancer patients. J Investig Med. 2026 May 20; 10815589261455329.
PMID: 42163009
Subcutaneous implantable cardioverter-defibrillator system malfunction during pelvic radiation therapy: Recognition and management of a rare complication.
Subcutaneous implantable cardioverter-defibrillator system malfunction during pelvic radiation therapy: Recognition and management of a rare complication. HeartRhythm Case Rep. 2026 Jul; 12(7):749-751.
PMID: 42472196
Sex-specific impact of body mass index on recurrence of atrial fibrillation after catheter ablation.
Sex-specific impact of body mass index on recurrence of atrial fibrillation after catheter ablation. Heart Rhythm O2. 2026 Apr; 7(4):675-685.
PMID: 42038675
Approach to Atrial Pacing in an Extracardiac Fontan Patient: Avoiding Trans-Baffle Puncture Through Electroanatomical Mapping.
Approach to Atrial Pacing in an Extracardiac Fontan Patient: Avoiding Trans-Baffle Puncture Through Electroanatomical Mapping. JACC Clin Electrophysiol. 2025 Dec; 11(12):2819-2823.
PMID: 41071159
Electrophysiological predictors of susceptible atrial substrate for the onset and recurrence of atrial fibrillation.
Electrophysiological predictors of susceptible atrial substrate for the onset and recurrence of atrial fibrillation. J Interv Card Electrophysiol. 2025 Apr; 68(3):635-642.
PMID: 39612095
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction.
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction. J Interv Card Electrophysiol. 2025 Jan; 68(1):111-116.
PMID: 39153133
Comparing outcomes after pulmonary vein isolation in patients with systolic and diastolic heart failure.
Comparing outcomes after pulmonary vein isolation in patients with systolic and diastolic heart failure. Heart Rhythm O2. 2024 Aug; 5(8):529-537.
PMID: 39263616
A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I.
A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. JAMA Cardiol. 2024 05 01; 9(5):449-456.
PMID: 38536171
Loss of heme oxygenase 2 causes reduced expression of genes in cardiac muscle development and contractility and leads to cardiomyopathy in mice.
Loss of heme oxygenase 2 causes reduced expression of genes in cardiac muscle development and contractility and leads to cardiomyopathy in mice. PLoS One. 2023; 18(10):e0292990.
PMID: 37844118